Robert L. Nussbaum's most recent trade in Invitae Corp was a trade of 17,404 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Dec. 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Invitae Corp | L. Robert Nussbaum | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 20 Dec 2023 | 17,404 | 551,941 (0%) | 0% | 0.6 | 11,278 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.38 per share. | 13 Jun 2023 | 7,086 | 569,345 (0%) | 0% | 1.4 | 9,757 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.20 per share. | 16 May 2023 | 26,476 | 576,431 (0%) | 0% | 1.2 | 31,753 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 155,000 | 602,907 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 13 Mar 2023 | 2,625 | 447,907 (0%) | 0% | 1.4 | 3,701 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2022 | 54,000 | 450,532 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 16 Aug 2022 | 7,048 | 396,532 (0%) | 0% | 4.6 | 32,071 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 17 May 2022 | 6,098 | 403,580 (0%) | 0% | 3.8 | 23,234 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2022 | 168,511 | 409,678 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 12 Mar 2022 | 19,588 | 241,167 (0%) | 0% | 6.7 | 130,993 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 14,705 | 260,755 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.89 per share. | 11 Nov 2021 | 29,675 | 246,050 (0%) | 0% | 21.9 | 649,568 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 16,406 | 53,594 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.23 per share. | 11 Nov 2021 | 16,406 | 275,725 (0%) | 0% | 10.2 | 167,833 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2021 | 13,269 | 40,080 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 11 Nov 2021 | 13,269 | 259,319 (0%) | 0% | 9.9 | 131,363 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.42 per share. | 16 Aug 2021 | 21,231 | 246,050 (0%) | 0% | 25.4 | 539,633 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 14 Jun 2021 | 9,910 | 266,879 (0%) | 0% | 31.6 | 313,405 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 44,700 | 276,789 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 23,200 | 23,200 | - | - | Employee Stock Option (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 11,894 | 238,354 (0%) | 0% | 42.9 | 510,260 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 15 Mar 2021 | 6,265 | 232,089 (0%) | 0% | 42.9 | 268,772 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 06 Jan 2021 | 10,101 | 225,312 (0%) | 0% | 9.9 | 100,000 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 10,101 | 53,349 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Oct 2020 | 6,550 | 63,450 | - | - | Employee Stock Options (right to buy) | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.90 per share. | 09 Oct 2020 | 6,550 | 215,211 (0%) | 0% | 9.9 | 64,845 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 10 Sep 2020 | 11,497 | 210,391 (0%) | 0% | 33.9 | 389,345 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 10 Sep 2020 | 9,391 | 221,888 (0%) | 0% | 33.0 | 309,591 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.69 per share. | 10 Sep 2020 | 1,730 | 208,661 (0%) | 0% | 34.7 | 60,012 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.87 per share. | 10 Sep 2020 | 557 | 231,279 (0%) | 0% | 33.9 | 18,864 | Common Stock |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 1,106 | 231,836 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Robert L. Nussbaum | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.10 per share. | 19 Aug 2020 | 19,049 | 230,730 (0%) | 0% | 32.1 | 611,399 | Common Stock |